IFAM
PCVX icon

Institutional & Family Asset Management’s Vaxcyte PCVX Stock Holding History

Institutional & Family Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$982 Hold
13
– – ﹤0.01% 646
2024
Q1 		$888 Hold
13
– – ﹤0.01% 648
2023
Q4 		$816 Hold
13
– – ﹤0.01% 635
2023
Q3 		$663 Hold
13
– – ﹤0.01% 646
2023
Q2 		$649 Buy
13
+5
+63% +$237 ﹤0.01% 661
2023
Q1 		$300 Buy
+8
New +$339 ﹤0.01% 700

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Institutional & Family Asset Management's PCVX Position: Q2 2024 in Review

Institutional & Family Asset Management held its Vaxcyte (PCVX) position steady in Q2 2024 at 13 shares worth $982. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Institutional & Family Asset Management first reported a position in PCVX in Q1 2023 and has held it in 6 quarters since. 265 funds tracked by Wall St. Rank hold PCVX as of Q2 2024.

  • Institutional & Family Asset Management held 13 shares of Vaxcyte worth $982 as of Q2 2024.
  • Institutional & Family Asset Management left its Vaxcyte share count unchanged in Q2 2024.
  • Vaxcyte made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #646 holding.
  • Institutional & Family Asset Management first reported a position in Vaxcyte in Q1 2023 and has held it in 6 quarters since.
  • 265 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.